Last week, the U.S. The post FDA Grants Breakthrough Therapy Designation to Beckley and Atai’s 5-MeO-DMT Program appeared first on Psychedelic Health.| Psychedelic Health
Arcadia Medicine, a San Francisco-based biotech startup developing MDMA-like empathogens, this month closed roughly $9.25 million in seed financing and won FDA clearance to begin human testing of an “safer” alternative to MDMA. The post What Is Sam Altman’s Involvement in MDMA Developer Arcadia, and Why Does It Matter? appeared first on Psychedelic Health.| Psychedelic Health
For the first time, data from real-world application of psilocybin treatment under a regulated program was published by one of the Oregon clinics providing treatment. The post What Happens At A Legal Psychedelics Center? Psilocybin Clinic Publishes Real-World Data For The First Time appeared first on Psychedelic Health.| Psychedelic Health
Psychedelic medicine took a major step forward this month as JAMA published results from the first randomized, placebo-controlled trial of LSD for anxiety. The post New Clinical Trial Shows LSD Can Improve Anxiety Symptoms appeared first on Psychedelic Health.| Psychedelic Health
AbbVie Inc. The post Pharma Giant AbbVie Makes $1.2 Billion Move into Psychedelics Depression Treatment appeared first on Psychedelic Health.| Psychedelic Health